Latest Embryonic stem cell Stories

Researchers at Washington University School of Medicine in St. Louis have identified a way to trigger reproduction in the laboratory of clusters of human cells that make insulin, potentially removing a significant obstacle to transplanting the cells as a treatment for patients with type 1 diabetes. Efforts to make this treatment possible have been limited by a dearth of insulin-producing beta cells that can be removed from donors after death, and by the stubborn refusal of human beta cells...

By transferring four genes into mouse fibroblast cells, researchers at the Icahn School of Medicine at Mount Sinai have produced cells that resemble hematopoietic stem cells, which produce millions of new blood cells in the human body every day. These findings provide a platform for future development of patient-specific stem/progenitor cells, and more differentiated blood products, for cell-replacement therapy. New York, NY (PRWEB) June 13, 2013 By transferring four genes into mouse...

In the latest issue of STEM CELLS Translational Medicine, a research team reports a new method which involves the creation of a highly stable and sensitive liver stem cell model. Durham, NC (PRWEB) June 11, 2013 The path to bringing a new drug to market is, simply put, a rocky one. Not only is it estimated to take over 12 years at an average price tag running anywhere between US $800 million and US $2 billion, but more often than not the new drug never makes it through the process. But...

University of Copenhagen Scientists at the Danish Stem Cell Center, DanStem, at the University of Copenhagen have discovered that they can make embryonic stem cells regress to a stage of development where they are able to make placenta cells as well as the other fetal cells. This significant discovery, published in the journal Cell Reports today, has the potential to shed new light on placenta related disorders that can lead to problematic pregnancies and miscarriages. Embryonic stem...

New data shows that human embryonic stem cells can be differentiated into liver progenitor cells and produce mature liver cells Liver transplantation is the mainstay of treatment for patients with end-stage liver disease, the 12th leading cause of death in the United States, but new research from the Icahn School of Medicine at Mount Sinai, published in the online journal Cell Stem Cell today, suggests that it may one day become possible to regenerate a liver using cell therapy in patients...

WNT3 helps pinpoint stem cell lines primed to turn into liver, pancreas and similar tissues; other genes may help select other lineages BOSTON, June 4, 2013 /PRNewswire-USNewswire/ -- According to researchers at Boston Children's Hospital, stem cells that strongly express a gene called WNT3 are biased to develop into cells and tissues including pancreas, liver and bladder. This discovery suggests that other genes may serve as biomarkers for selecting stem cells with a preference for...

Stem Cells from our own bodies show promise in repairing and reversing diseases otherwise thought of as incurable by conventional medicine. Guy DaSilva, MD is excited to offer Stem Cell Therapy in Sarasota, Florida at the DaSilva Institute of Anti-Aging, Regenerative & Functional Medicine. Sarasota, Florida (PRWEB) June 03, 2013 Guy DaSilva, MD, ABAARM, will begin conducting clinical trials for many degenerative diseases using adipose-derived stem cell therapy at the DaSilva...

Transplantation of human stem cells in an experiment conducted at the University of Wisconsin-Madison improved survival and muscle function in rats used to model ALS, a nerve disease that destroys nerve control of muscles, causing death by respiratory failure. ALS (amyotrophic lateral sclerosis) is sometimes called "Lou Gehrig's disease." According to the ALS Association, the condition strikes about 5,600 Americans each year. Only about half of patients are alive three years after...

Brett Smith for redOrbit.com - Your Universe Online For years, stem-cell based therapies have been described as a potential way to treat spinal cord injuries in humans, and a new study published in the journal Stem Cell Research and Therapy describes an exciting step forward in that pursuit. According to the report, a single injection of human stem cells was able to induce neuronal regeneration and improved mobility in rats that were afflicted with a severe spinal cord injury. "This...

LOS ANGELES, May 22, 2013 /PRNewswire/ -- Kathy Ireland, CEO and Chief Designer of kathy ireland Worldwide (kiWW) and leading women's health advocate, and world-renowned board certified surgeon Dr. David Scharp today announced their collaboration in bringing to the beauty market a stem cell-derived product brand named Stemage. They note that the unique aspect of the natural skin rejuvenation system is that it targets visible signs of aging through the unique and proprietary use of...